Literature DB >> 26172133

Consensus conference on hilar cholangiocarcinoma.

Christopher E Forsmark1, Alessandro L Diniz2, Andrew X Zhu3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26172133      PMCID： PMC4527851          DOI： 10.1111/hpb.12451

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN： 1365-182X            Impact factor:   3.647


× No keyword cloud information.
  10 in total

1.  Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma.

Authors:  Dario Ribero; Marco Amisano; Roberto Lo Tesoriere; Stefano Rosso; Alessandro Ferrero; Lorenzo Capussotti
Journal:  Ann Surg       Date:  2011-11       Impact factor: 12.969

2.  Percutaneous transhepatic biliary drainage catheter tract recurrence in cholangiocarcinoma.

Authors:  Y Takahashi; M Nagino; H Nishio; T Ebata; T Igami; Y Nimura
Journal:  Br J Surg       Date:  2010-08-26       Impact factor: 6.939

Review 3.  Portal vein embolization in hilar cholangiocarcinoma.

Authors:  Martin Palavecino; Eddie K Abdalla; David C Madoff; Jean-Nicolas Vauthey
Journal:  Surg Oncol Clin N Am       Date:  2009-04       Impact factor: 3.495

4.  Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

Authors:  Juan Valle; Harpreet Wasan; Daniel H Palmer; David Cunningham; Alan Anthoney; Anthony Maraveyas; Srinivasan Madhusudan; Tim Iveson; Sharon Hughes; Stephen P Pereira; Michael Roughton; John Bridgewater
Journal:  N Engl J Med       Date:  2010-04-08       Impact factor: 91.245

Review 5.  Future directions in the treatment of cholangiocarcinoma.

Authors:  Andrew X Zhu
Journal:  Best Pract Res Clin Gastroenterol       Date:  2015-02-19       Impact factor: 3.043

6.  Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma.

Authors:  Daniela Sia; Bojan Losic; Agrin Moeini; Laia Cabellos; Ke Hao; Kate Revill; Dennis Bonal; Oriana Miltiadous; Zhongyang Zhang; Yujin Hoshida; Helena Cornella; Mireia Castillo-Martin; Roser Pinyol; Yumi Kasai; Sasan Roayaie; Swan N Thung; Josep Fuster; Myron E Schwartz; Samuel Waxman; Carlos Cordon-Cardo; Eric Schadt; Vincenzo Mazzaferro; Josep M Llovet
Journal:  Nat Commun       Date:  2015-01-22       Impact factor: 14.919

Review 7.  Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system.

Authors:  E C Burke; W R Jarnagin; S N Hochwald; P W Pisters; Y Fong; L H Blumgart
Journal:  Ann Surg       Date:  1998-09       Impact factor: 12.969

8.  Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma.

Authors:  Rondell P Graham; Emily G Barr Fritcher; Ekaterina Pestova; John Schulz; Leonid A Sitailo; George Vasmatzis; Stephen J Murphy; Robert R McWilliams; Steven N Hart; Kevin C Halling; Lewis R Roberts; Gregory J Gores; Fergus J Couch; Lizhi Zhang; Mitesh J Borad; Benjamin R Kipp
Journal:  Hum Pathol       Date:  2014-04-13       Impact factor: 3.466

9.  Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.

Authors:  Yuchen Jiao; Timothy M Pawlik; Robert A Anders; Florin M Selaru; Mirte M Streppel; Donald J Lucas; Noushin Niknafs; Violeta Beleva Guthrie; Anirban Maitra; Pedram Argani; G Johan A Offerhaus; Juan Carlos Roa; Lewis R Roberts; Gregory J Gores; Irinel Popescu; Sorin T Alexandrescu; Simona Dima; Matteo Fassan; Michele Simbolo; Andrea Mafficini; Paola Capelli; Rita T Lawlor; Andrea Ruzzenente; Alfredo Guglielmi; Giampaolo Tortora; Filippo de Braud; Aldo Scarpa; William Jarnagin; David Klimstra; Rachel Karchin; Victor E Velculescu; Ralph H Hruban; Bert Vogelstein; Kenneth W Kinzler; Nickolas Papadopoulos; Laura D Wood
Journal:  Nat Genet       Date:  2013-11-03       Impact factor: 38.330

10.  Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas.

Authors:  P Wang; Q Dong; C Zhang; P-F Kuan; Y Liu; W R Jeck; J B Andersen; W Jiang; G L Savich; T-X Tan; J T Auman; J M Hoskins; A D Misher; C D Moser; S M Yourstone; J W Kim; K Cibulskis; G Getz; H V Hunt; S S Thorgeirsson; L R Roberts; D Ye; K-L Guan; Y Xiong; L-X Qin; D Y Chiang
Journal:  Oncogene       Date:  2012-07-23       Impact factor: 8.756
  10 in total
  5 in total

1.  Y-Shaped, Self-Expanding Metallic Stents (SEMS) to Drain Malignant Strictures of the Liver Hilum: Y Are They Better?

Authors:  John Baillie; Ravi Vachhani
Journal:  Dig Dis Sci       Date:  2017-01       Impact factor: 3.199

2.  Surgical management of biliary malignancy.

Authors:  T Peter Kingham; Victoria G Aveson; Alice C Wei; Jason A Castellanos; Peter J Allen; Daniel P Nussbaum; Yinin Hu; Michael I D'Angelica
Journal:  Curr Probl Surg       Date:  2020-06-30       Impact factor: 1.909

Review 3.  Effect of preoperative cholangitis on prognosis of patients with hilar cholangiocarcinoma: A systematic review and meta-analysis.

Authors:  Yudong Wang; Wenkang Fu; Zengwei Tang; Wenbo Meng; Wence Zhou; Xun Li
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

4.  18F-FDG PET/CT may be a suitable method for preoperative diagnosis and evaluation of Chinese older patients with hilar cholangiocarcinoma.

Authors:  Xuling Li; Ying Zhang; Yongyang Zhang
Journal:  BMC Geriatr       Date:  2018-07-06       Impact factor: 3.921

Review 5.  Tourniquet-ALPPS is a promising treatment for very large hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Authors:  Victor López-López; Ricardo Robles-Campos; Robeto Brusadin; Asunción López-Conesa; Álvaro Navarro; Julio Arevalo-Perez; Pedro Jose Gil; Pascual Parrilla
Journal:  Oncotarget       Date:  2018-06-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.